Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Chromone-Embedded Peptidomimetics and Furopyrimidines As Highly Potent Sars-Cov-2 Infection Inhibitors: Docking and Md Simulation Study Publisher Pubmed



Shakibay Senobari Z1 ; Masoumian Hosseini M2, 3 ; Teimouri MB4 ; Rezayan AH5 ; Samarghandian S6 ; Hekmat A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
  2. 2. Department of Biochemistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of E-Learning in Medical Science, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Faculty of Chemistry, Kharazmi University, Tehran, Iran
  5. 5. Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, 1417466191, Iran
  6. 6. Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran

Source: BMC Research Notes Published:2023


Abstract

Background: COVID-19 is a respiratory illness caused by SARS-CoV-2. Pharmaceutical companies aim to control virus spread through effective drugs. This study investigates chromone compound derivatives’ ability to inhibit viral entry and prevent replication. Method: This study investigated the inhibitory effect of chromone-embedded peptidomimetics and furopyrimidines on 7BZ5 from Severe Acute Respiratory Syndrome CoV-2, Homo sapiens, and 6LU7 from Bat SARS-like CoV using molecular docking. The crystal structure of these proteins was obtained from the Protein Data Bank, and the inhibition site was determined using ligand binding interaction options. The 3D structure was protonated and energetically minimised using MOE software. Chromone derivatives were designed in three dimensions, and their energy was minimised using MOE 2019. The molecular drug-likeness was calculated using SwissADME, Lipinski and Benigni-Bossa’s rule, and toxicity was calculated using Toxtree v3.1.0 software. Compounds with pharmacological properties were selected for molecular docking, and interactions were assessed using MOE 2019. MD simulations of Mpro-ch-p complexes were performed to evaluate root mean square fluctuations (RMSF) and measure protein stability. Result: The pharmacokinetic tests revealed that chromone derivatives of the peptidomimetic family have acceptable pharmacokinetic activity in the human body. Some compounds, such as Ch-p1, Ch-p2, Ch-p6, Ch-p7, Ch-p12, and Ch-p13, have pronounced medicinal properties. Molecular docking revealed high affinity for binding to SARS-CoV-2 protease. Ch-p7 had the highest binding energy, likely due to its inhibitory property. A 10 ns molecular dynamics study confirmed the stability of the protein–ligand complex, resulting in minimal fluctuations in the system's backbone. The MM-GBSA analysis revealed free energies of binding of − 19.54 kcal/mol. Conclusions: The study investigated the inhibition of viral replication using chromone derivatives, finding high inhibitory effects in the peptidomimetic family compared to other studies. © 2023, BioMed Central Ltd., part of Springer Nature.
Other Related Docs
14. Photobiomodulation and Antiviral Photodynamic Therapy in Covid-19 Management, Advances in Experimental Medicine and Biology (2021)
16. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)
17. Sars-Cov-2; What We Know so Far, Archives of Iranian Medicine (2020)
21. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)
30. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
31. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
32. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
36. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
43. Variable Clinical Manifestations of Covid-19: Viral and Human Genomes Talk, Iranian Journal of Allergy# Asthma and Immunology (2020)